全球智库信息集成服务系统

In our case studies we see evidence that, over the past 10 years, NIHR has transformed R&D in and for the NHS and the people it serves:

NIHR is improving the health of the public nationally and internationally.

• NIHR-supported public health research is leading to reductions in alcohol-related harm, improving smoking prevention strategies and increasing vaccination coverage for H1N1 and childhood immunisation. Worldwide, more than 1 million people stand to benefit from NIHR-funded research into the off-label use of tranexamic acid to aid clotting during traumatic bleeding.

NIHR is making the nation's healthcare system more effective, cost-effective and safer.

• NIHR-funded research into patient safety has informed the World Health Organization's (WHO) Surgical Safety Checklist, which is significantly reducing post-operative complications. Other research is identifying cost-effective solutions that save money in areas ranging from physical therapy, to dementia, to diabetes

NIHR helps put patients and the public at the heart of research.

• NIHR is a world leader in patient and public involvement, and there have been tangible improvements to how research is able to deliver patient benefit. INVOLVE, NIHR-funded national public involvement centre and advisory group, helps ensure that patients and the public are effectively involved at all stages of research studies, making them more acceptable and meaningful for research users of all ages.

NIHR supports a research infrastructure in the NHS.

• NIHR supports a national research infrastructure of world-class research centres, units and facilities, as well as the Clinical Research Network. Together these provide coverage across the health research system in England and enable and facilitate both research funded by NIHR itself and research funded through charities, industry, and other government funders. In 2014/15, from an initial investment of £227.8 million, NIHR research infrastructure leveraged £1.06 billion in research funding from NIHR's public, charity and industry research funding partners.